| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Bladder | 38 | 2022 | 1139 | 4.840 |
Why?
|
| Muscle, Smooth | 24 | 2018 | 955 | 2.810 |
Why?
|
| Spinal Cord Injuries | 8 | 2020 | 992 | 2.200 |
Why?
|
| Inosine | 3 | 2018 | 134 | 1.810 |
Why?
|
| Myocytes, Smooth Muscle | 12 | 2014 | 735 | 1.750 |
Why?
|
| Urinary Bladder Neoplasms | 12 | 2022 | 2100 | 1.590 |
Why?
|
| Urothelium | 11 | 2019 | 289 | 1.520 |
Why?
|
| Neuropilin-2 | 3 | 2017 | 48 | 1.250 |
Why?
|
| Platelet-Derived Growth Factor | 7 | 2015 | 643 | 1.230 |
Why?
|
| Carcinoma, Transitional Cell | 7 | 2022 | 769 | 1.150 |
Why?
|
| Epidermal Growth Factor | 20 | 2005 | 726 | 0.970 |
Why?
|
| Muscle Contraction | 8 | 2018 | 1250 | 0.970 |
Why?
|
| Urinary Bladder Diseases | 4 | 2020 | 174 | 0.960 |
Why?
|
| Urinary Bladder, Overactive | 3 | 2017 | 101 | 0.770 |
Why?
|
| Urinary Bladder Neck Obstruction | 4 | 2017 | 84 | 0.760 |
Why?
|
| Proto-Oncogene Proteins c-akt | 10 | 2017 | 2593 | 0.760 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 2018 | 161 | 0.740 |
Why?
|
| Tissue Scaffolds | 7 | 2014 | 939 | 0.690 |
Why?
|
| Membrane Microdomains | 8 | 2008 | 213 | 0.680 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2011 | 587 | 0.670 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 22 | 2012 | 1752 | 0.660 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2017 | 131 | 0.600 |
Why?
|
| Fibroins | 4 | 2021 | 63 | 0.580 |
Why?
|
| Systems Biology | 1 | 2020 | 493 | 0.580 |
Why?
|
| Silk | 5 | 2014 | 91 | 0.560 |
Why?
|
| Host vs Graft Reaction | 1 | 2014 | 15 | 0.550 |
Why?
|
| Cell Separation | 1 | 2020 | 1829 | 0.520 |
Why?
|
| Mucous Membrane | 1 | 2018 | 670 | 0.510 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 817 | 0.490 |
Why?
|
| Regeneration | 10 | 2021 | 1544 | 0.490 |
Why?
|
| Glycoproteins | 4 | 2010 | 2318 | 0.480 |
Why?
|
| Actins | 4 | 2013 | 2189 | 0.470 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2022 | 3016 | 0.470 |
Why?
|
| Cyclin A1 | 1 | 2012 | 12 | 0.460 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2017 | 997 | 0.460 |
Why?
|
| Laminectomy | 1 | 2013 | 238 | 0.440 |
Why?
|
| Biocompatible Materials | 5 | 2014 | 1720 | 0.440 |
Why?
|
| Evoked Potentials | 1 | 2018 | 1042 | 0.440 |
Why?
|
| GATA6 Transcription Factor | 2 | 2010 | 48 | 0.420 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2013 | 662 | 0.420 |
Why?
|
| Spinal Cord Compression | 1 | 2013 | 225 | 0.420 |
Why?
|
| Rats | 23 | 2018 | 25091 | 0.420 |
Why?
|
| Growth Substances | 4 | 2005 | 813 | 0.410 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2015 | 3008 | 0.400 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2013 | 850 | 0.400 |
Why?
|
| Ureter | 3 | 2015 | 363 | 0.390 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2022 | 2961 | 0.390 |
Why?
|
| Thrombomodulin | 1 | 2010 | 102 | 0.380 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2161 | 0.360 |
Why?
|
| Tissue Engineering | 7 | 2017 | 1855 | 0.360 |
Why?
|
| Chromosome Deletion | 2 | 2010 | 1378 | 0.350 |
Why?
|
| Signal Transduction | 26 | 2021 | 23996 | 0.350 |
Why?
|
| Animals | 63 | 2022 | 170890 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2010 | 545 | 0.350 |
Why?
|
| Endopeptidases | 1 | 2012 | 844 | 0.340 |
Why?
|
| Myristic Acid | 1 | 2007 | 49 | 0.330 |
Why?
|
| Cell Fractionation | 1 | 2008 | 290 | 0.330 |
Why?
|
| Transcription Factor AP-1 | 5 | 2014 | 328 | 0.320 |
Why?
|
| Carcinoma | 4 | 2013 | 2325 | 0.320 |
Why?
|
| Isometric Contraction | 2 | 2018 | 152 | 0.320 |
Why?
|
| Cell Movement | 5 | 2014 | 5465 | 0.310 |
Why?
|
| Urodynamics | 4 | 2017 | 360 | 0.310 |
Why?
|
| Cyclooxygenase 2 | 2 | 2007 | 631 | 0.310 |
Why?
|
| Androgen Receptor Antagonists | 2 | 2009 | 117 | 0.310 |
Why?
|
| Disease Models, Animal | 10 | 2017 | 18352 | 0.300 |
Why?
|
| Keratin-5 | 2 | 2017 | 46 | 0.290 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2005 | 729 | 0.290 |
Why?
|
| Telomerase | 1 | 2010 | 744 | 0.290 |
Why?
|
| rho-Associated Kinases | 4 | 2013 | 291 | 0.280 |
Why?
|
| Cholesterol | 5 | 2007 | 2894 | 0.280 |
Why?
|
| Proteomics | 4 | 2020 | 3268 | 0.280 |
Why?
|
| Caveolae | 1 | 2004 | 56 | 0.270 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 803 | 0.270 |
Why?
|
| Prostatic Neoplasms | 17 | 2015 | 10651 | 0.260 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2005 | 471 | 0.250 |
Why?
|
| Genomics | 1 | 2020 | 5338 | 0.250 |
Why?
|
| Bladder Exstrophy | 1 | 2005 | 92 | 0.250 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2021 | 8600 | 0.250 |
Why?
|
| Mice | 35 | 2021 | 81126 | 0.240 |
Why?
|
| Gene Expression Profiling | 5 | 2021 | 9532 | 0.240 |
Why?
|
| Caspases | 2 | 2007 | 967 | 0.240 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2017 | 8685 | 0.230 |
Why?
|
| Cell Survival | 6 | 2020 | 6133 | 0.230 |
Why?
|
| Prostate | 8 | 2008 | 1604 | 0.230 |
Why?
|
| Phosphorylation | 12 | 2015 | 8743 | 0.230 |
Why?
|
| Cells, Cultured | 21 | 2016 | 20095 | 0.220 |
Why?
|
| Synaptotagmin II | 1 | 2021 | 17 | 0.220 |
Why?
|
| Subrenal Capsule Assay | 1 | 2001 | 27 | 0.220 |
Why?
|
| Cystitis, Interstitial | 1 | 2021 | 61 | 0.220 |
Why?
|
| Enzyme Inhibitors | 7 | 2005 | 3933 | 0.220 |
Why?
|
| Synaptotagmin I | 1 | 2021 | 39 | 0.220 |
Why?
|
| Gene Expression Regulation | 6 | 2013 | 12433 | 0.210 |
Why?
|
| Urinary Tract | 2 | 2015 | 295 | 0.210 |
Why?
|
| Stress, Mechanical | 7 | 2005 | 1705 | 0.210 |
Why?
|
| Caveolin 1 | 3 | 2013 | 257 | 0.210 |
Why?
|
| Prostatic Hyperplasia | 3 | 2003 | 508 | 0.210 |
Why?
|
| Humans | 84 | 2022 | 717237 | 0.210 |
Why?
|
| Membrane Proteins | 6 | 2018 | 8109 | 0.200 |
Why?
|
| Amides | 1 | 2003 | 457 | 0.200 |
Why?
|
| T-Box Domain Proteins | 2 | 2015 | 472 | 0.200 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2007 | 1377 | 0.200 |
Why?
|
| Androgens | 4 | 2007 | 1231 | 0.200 |
Why?
|
| RNA, Messenger | 12 | 2021 | 13301 | 0.190 |
Why?
|
| Botulinum Toxins | 1 | 2021 | 187 | 0.190 |
Why?
|
| Receptors, Androgen | 5 | 2013 | 1061 | 0.190 |
Why?
|
| Cell Line | 7 | 2017 | 16693 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 2 | 2004 | 1997 | 0.190 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2013 | 4697 | 0.190 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 36 | 0.180 |
Why?
|
| Shiga Toxins | 1 | 2018 | 42 | 0.180 |
Why?
|
| Phenotype | 4 | 2020 | 16404 | 0.180 |
Why?
|
| Arsenic | 1 | 2022 | 323 | 0.180 |
Why?
|
| Transcription Factors | 5 | 2013 | 12073 | 0.180 |
Why?
|
| Ricin | 1 | 2018 | 75 | 0.180 |
Why?
|
| Muscle Relaxation | 2 | 2011 | 144 | 0.170 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2018 | 113 | 0.170 |
Why?
|
| Neoplasm Metastasis | 5 | 2017 | 5101 | 0.170 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2021 | 424 | 0.170 |
Why?
|
| Tretinoin | 2 | 2011 | 530 | 0.160 |
Why?
|
| Calibration | 1 | 2020 | 799 | 0.160 |
Why?
|
| Cell Proliferation | 9 | 2019 | 10802 | 0.160 |
Why?
|
| Receptors, Muscarinic | 1 | 2018 | 162 | 0.160 |
Why?
|
| Perioperative Period | 1 | 2019 | 265 | 0.160 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2022 | 174 | 0.160 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2017 | 51 | 0.160 |
Why?
|
| Xanthines | 1 | 2017 | 123 | 0.160 |
Why?
|
| Apoptosis | 9 | 2019 | 10119 | 0.160 |
Why?
|
| Cobalt | 1 | 2017 | 162 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 9 | 2013 | 6564 | 0.150 |
Why?
|
| TRPV Cation Channels | 3 | 2015 | 233 | 0.150 |
Why?
|
| Cell Line, Tumor | 13 | 2019 | 16989 | 0.150 |
Why?
|
| Perfusion | 1 | 2020 | 1276 | 0.150 |
Why?
|
| Reconstructive Surgical Procedures | 3 | 2021 | 2127 | 0.150 |
Why?
|
| Myosin Light Chains | 2 | 2013 | 129 | 0.140 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 362 | 0.140 |
Why?
|
| Synaptophysin | 1 | 2015 | 141 | 0.140 |
Why?
|
| DNA | 4 | 2005 | 7166 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 649 | 0.140 |
Why?
|
| Stromal Cells | 3 | 2017 | 1362 | 0.140 |
Why?
|
| RNA, Small Interfering | 4 | 2013 | 3615 | 0.140 |
Why?
|
| Urinary Tract Infections | 1 | 2021 | 781 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2016 | 3512 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2009 | 4935 | 0.140 |
Why?
|
| Chromium | 1 | 2016 | 133 | 0.140 |
Why?
|
| Cell Division | 10 | 2009 | 4735 | 0.140 |
Why?
|
| Chromosomal Instability | 1 | 2016 | 166 | 0.140 |
Why?
|
| Transfection | 7 | 2013 | 6142 | 0.140 |
Why?
|
| Bombyx | 2 | 2013 | 55 | 0.140 |
Why?
|
| Triazines | 1 | 2017 | 311 | 0.130 |
Why?
|
| Intestinal Mucosa | 3 | 2014 | 3061 | 0.130 |
Why?
|
| Esophagus | 1 | 2021 | 1018 | 0.130 |
Why?
|
| Gene Silencing | 4 | 2015 | 1616 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-sis | 3 | 2004 | 256 | 0.130 |
Why?
|
| Fibroblast Growth Factor 2 | 4 | 2003 | 634 | 0.130 |
Why?
|
| Epigenomics | 1 | 2020 | 813 | 0.130 |
Why?
|
| Hepatectomy | 2 | 2019 | 563 | 0.130 |
Why?
|
| Guided Tissue Regeneration | 1 | 2014 | 93 | 0.130 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 2010 | 444 | 0.130 |
Why?
|
| Potassium Channels | 1 | 2017 | 573 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2022 | 4038 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2014 | 292 | 0.120 |
Why?
|
| Flow Cytometry | 4 | 2020 | 6132 | 0.120 |
Why?
|
| Paracrine Communication | 1 | 2015 | 284 | 0.120 |
Why?
|
| Down-Regulation | 3 | 2012 | 3094 | 0.120 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2013 | 41 | 0.120 |
Why?
|
| Urologic Surgical Procedures | 2 | 2013 | 293 | 0.120 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2013 | 46 | 0.120 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 1385 | 0.120 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2013 | 23 | 0.120 |
Why?
|
| Mitral Valve | 1 | 2022 | 1458 | 0.120 |
Why?
|
| Cell Nucleus | 4 | 2008 | 3018 | 0.120 |
Why?
|
| Neurofilament Proteins | 1 | 2015 | 362 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 4 | 2015 | 2816 | 0.120 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2013 | 51 | 0.120 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 4046 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2918 | 0.120 |
Why?
|
| Male | 38 | 2021 | 351380 | 0.110 |
Why?
|
| Muscle Proteins | 2 | 2013 | 1235 | 0.110 |
Why?
|
| Genes, Dominant | 1 | 2015 | 904 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2022 | 3010 | 0.110 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 9804 | 0.110 |
Why?
|
| Kidney | 2 | 2005 | 6910 | 0.110 |
Why?
|
| Pyridines | 2 | 2003 | 2871 | 0.110 |
Why?
|
| Polymerization | 1 | 2013 | 173 | 0.110 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 1789 | 0.110 |
Why?
|
| Taxoids | 1 | 2015 | 648 | 0.110 |
Why?
|
| Neoplasm Transplantation | 3 | 2006 | 2149 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 3 | 2013 | 906 | 0.110 |
Why?
|
| Tenascin | 1 | 2011 | 56 | 0.110 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2013 | 293 | 0.110 |
Why?
|
| Urethra | 1 | 2014 | 409 | 0.110 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2011 | 100 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2004 | 1320 | 0.110 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 255 | 0.110 |
Why?
|
| Cell Membrane | 3 | 2007 | 3918 | 0.110 |
Why?
|
| Up-Regulation | 4 | 2012 | 4356 | 0.100 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2011 | 62 | 0.100 |
Why?
|
| Neurosecretory Systems | 2 | 2003 | 238 | 0.100 |
Why?
|
| Triazoles | 1 | 2017 | 922 | 0.100 |
Why?
|
| Epithelial Cells | 7 | 2021 | 3694 | 0.100 |
Why?
|
| Cell Shape | 1 | 2012 | 379 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1730 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 4594 | 0.100 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 250 | 0.100 |
Why?
|
| Lymphedema | 1 | 2016 | 421 | 0.100 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 4101 | 0.100 |
Why?
|
| Cell-Derived Microparticles | 1 | 2012 | 165 | 0.100 |
Why?
|
| Sus scrofa | 1 | 2012 | 455 | 0.100 |
Why?
|
| Wound Healing | 3 | 2018 | 2800 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 2 | 2015 | 1729 | 0.100 |
Why?
|
| Disease Progression | 5 | 2019 | 13307 | 0.100 |
Why?
|
| Detergents | 2 | 2008 | 236 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2013 | 567 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3564 | 0.100 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2010 | 180 | 0.100 |
Why?
|
| Cytogenetic Analysis | 1 | 2010 | 308 | 0.100 |
Why?
|
| Facial Bones | 1 | 2011 | 208 | 0.090 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2009 | 15 | 0.090 |
Why?
|
| GATA4 Transcription Factor | 1 | 2010 | 138 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2017 | 3807 | 0.090 |
Why?
|
| Microtubules | 1 | 2015 | 1209 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2009 | 204 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 3697 | 0.090 |
Why?
|
| Cell Differentiation | 7 | 2017 | 11758 | 0.090 |
Why?
|
| Cell Culture Techniques | 2 | 2010 | 1722 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 6 | 2013 | 6051 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2011 | 493 | 0.090 |
Why?
|
| Cell Growth Processes | 2 | 2006 | 412 | 0.090 |
Why?
|
| Immunohistochemistry | 8 | 2015 | 11777 | 0.090 |
Why?
|
| Species Specificity | 1 | 2013 | 2620 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2011 | 490 | 0.090 |
Why?
|
| Solubility | 2 | 2017 | 1163 | 0.080 |
Why?
|
| Mice, SCID | 3 | 2005 | 2845 | 0.080 |
Why?
|
| Calcium Channels | 2 | 2002 | 657 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 1098 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2010 | 781 | 0.080 |
Why?
|
| Cyclodextrins | 1 | 2007 | 52 | 0.080 |
Why?
|
| Peritoneal Neoplasms | 1 | 2013 | 629 | 0.080 |
Why?
|
| Mitogens | 3 | 2003 | 252 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 573 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2017 | 1932 | 0.080 |
Why?
|
| Tumor Burden | 1 | 2013 | 1916 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2012 | 2049 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2013 | 1211 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2012 | 1227 | 0.080 |
Why?
|
| Colorectal Neoplasms | 2 | 2019 | 6590 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3469 | 0.080 |
Why?
|
| Muscles | 1 | 2011 | 1630 | 0.070 |
Why?
|
| Skull | 1 | 2011 | 812 | 0.070 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2003 | 136 | 0.070 |
Why?
|
| Female | 22 | 2021 | 377909 | 0.070 |
Why?
|
| Enzyme Activation | 4 | 2008 | 3873 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2021 | 3680 | 0.070 |
Why?
|
| Models, Animal | 3 | 2021 | 2220 | 0.070 |
Why?
|
| Caspase 9 | 1 | 2005 | 196 | 0.070 |
Why?
|
| Phenanthridines | 1 | 2005 | 59 | 0.070 |
Why?
|
| Interleukin-6 | 3 | 2004 | 3216 | 0.070 |
Why?
|
| Neuropilin-1 | 1 | 2005 | 91 | 0.070 |
Why?
|
| Fibroblast Growth Factor 9 | 1 | 2004 | 15 | 0.070 |
Why?
|
| Receptor, PAR-2 | 1 | 2004 | 33 | 0.070 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2004 | 69 | 0.070 |
Why?
|
| Zinc Fingers | 1 | 2007 | 598 | 0.070 |
Why?
|
| Culture Media, Conditioned | 2 | 2005 | 550 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 2176 | 0.070 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2007 | 330 | 0.070 |
Why?
|
| Dihydrotestosterone | 2 | 2002 | 193 | 0.070 |
Why?
|
| Prostate-Specific Antigen | 3 | 2013 | 2281 | 0.070 |
Why?
|
| Quantum Dots | 1 | 2006 | 173 | 0.070 |
Why?
|
| Hypertrophy | 2 | 2003 | 577 | 0.060 |
Why?
|
| Cardiovascular System | 1 | 2011 | 770 | 0.060 |
Why?
|
| Binding Sites | 3 | 2009 | 6295 | 0.060 |
Why?
|
| Cell Physiological Phenomena | 1 | 2005 | 156 | 0.060 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 7952 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2018 | 3008 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2006 | 2022 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2012 | 2834 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2004 | 287 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 860 | 0.060 |
Why?
|
| DNA Primers | 5 | 2011 | 2999 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2008 | 2249 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 1990 | 944 | 0.060 |
Why?
|
| Heparin | 4 | 2001 | 1637 | 0.060 |
Why?
|
| Neurofibromin 1 | 1 | 2004 | 204 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2007 | 1529 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2005 | 801 | 0.060 |
Why?
|
| Intestines | 1 | 2012 | 1932 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2015 | 315 | 0.060 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2004 | 351 | 0.060 |
Why?
|
| Hormones | 1 | 2006 | 857 | 0.060 |
Why?
|
| Membrane Lipids | 1 | 2003 | 255 | 0.060 |
Why?
|
| Base Sequence | 6 | 2015 | 13317 | 0.060 |
Why?
|
| Immunoblotting | 2 | 2003 | 1792 | 0.060 |
Why?
|
| Gingiva | 1 | 2004 | 339 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 2 | 2012 | 3704 | 0.060 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 1604 | 0.060 |
Why?
|
| Peptides | 1 | 2014 | 4438 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2011 | 11200 | 0.050 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 2459 | 0.050 |
Why?
|
| Oligonucleotides | 1 | 2004 | 603 | 0.050 |
Why?
|
| Calcium Signaling | 2 | 2003 | 757 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2022 | 2612 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 11423 | 0.050 |
Why?
|
| Receptors, Angiotensin | 1 | 2000 | 144 | 0.050 |
Why?
|
| Oncogene Proteins v-erbB | 1 | 1999 | 19 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2005 | 1812 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 4480 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2017 | 4286 | 0.050 |
Why?
|
| Kidney Cortex | 1 | 2000 | 185 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2021 | 449 | 0.050 |
Why?
|
| Stem Cells | 1 | 2013 | 3597 | 0.050 |
Why?
|
| Urethral Obstruction | 1 | 1999 | 53 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2003 | 650 | 0.050 |
Why?
|
| Trihexosylceramides | 1 | 2018 | 31 | 0.050 |
Why?
|
| Sheep | 1 | 2022 | 1477 | 0.050 |
Why?
|
| Endothelium | 1 | 2022 | 804 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2004 | 841 | 0.040 |
Why?
|
| Periodicity | 1 | 2000 | 378 | 0.040 |
Why?
|
| Cell Transplantation | 1 | 2001 | 497 | 0.040 |
Why?
|
| Tumor Microenvironment | 3 | 2017 | 3100 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 22929 | 0.040 |
Why?
|
| Blotting, Western | 4 | 2015 | 5438 | 0.040 |
Why?
|
| Genes, erbB-1 | 1 | 1999 | 170 | 0.040 |
Why?
|
| Glycosphingolipids | 1 | 2018 | 81 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2015 | 359 | 0.040 |
Why?
|
| Protein Transport | 2 | 2018 | 2066 | 0.040 |
Why?
|
| Ureteral Obstruction | 1 | 2000 | 300 | 0.040 |
Why?
|
| France | 1 | 2019 | 489 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2018 | 3243 | 0.040 |
Why?
|
| Glycolipids | 1 | 2018 | 215 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17432 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2016 | 6676 | 0.040 |
Why?
|
| Neuroblastoma | 1 | 2005 | 1181 | 0.040 |
Why?
|
| Mutagenicity Tests | 1 | 2017 | 44 | 0.040 |
Why?
|
| Protein Kinase C | 2 | 2005 | 1278 | 0.040 |
Why?
|
| Leucovorin | 1 | 2019 | 602 | 0.040 |
Why?
|
| Organoplatinum Compounds | 1 | 2019 | 430 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2018 | 4329 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2018 | 431 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 2 | 2002 | 1587 | 0.040 |
Why?
|
| Models, Biological | 3 | 2012 | 9892 | 0.040 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 290 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2003 | 1189 | 0.040 |
Why?
|
| Endothelial Growth Factors | 1 | 1999 | 695 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2022 | 718 | 0.040 |
Why?
|
| Hyperplasia | 2 | 2015 | 1173 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2016 | 232 | 0.040 |
Why?
|
| Oxidative Stress | 2 | 2005 | 3179 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 2593 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 2441 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2017 | 136 | 0.040 |
Why?
|
| Gene Expression | 4 | 2003 | 8013 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2017 | 148 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 13754 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 420 | 0.040 |
Why?
|
| Lymphokines | 1 | 1999 | 968 | 0.040 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 18738 | 0.040 |
Why?
|
| Urine | 1 | 2017 | 380 | 0.040 |
Why?
|
| Extracellular Space | 1 | 1998 | 612 | 0.040 |
Why?
|
| Endosomes | 1 | 2018 | 537 | 0.040 |
Why?
|
| Epothilones | 1 | 2015 | 47 | 0.040 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 7056 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3993 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5988 | 0.030 |
Why?
|
| Proteome | 1 | 2005 | 1776 | 0.030 |
Why?
|
| Aging | 1 | 2014 | 8376 | 0.030 |
Why?
|
| Glycosylation | 1 | 2018 | 1138 | 0.030 |
Why?
|
| Hydrostatic Pressure | 1 | 2015 | 108 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 6370 | 0.030 |
Why?
|
| Lovastatin | 1 | 2015 | 117 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 651 | 0.030 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 1593 | 0.030 |
Why?
|
| Phylogeny | 1 | 2022 | 2807 | 0.030 |
Why?
|
| Receptors, Prostaglandin | 1 | 2014 | 61 | 0.030 |
Why?
|
| Trans-Activators | 2 | 2003 | 3069 | 0.030 |
Why?
|
| Japan | 1 | 2019 | 1367 | 0.030 |
Why?
|
| Mutation | 3 | 2015 | 29491 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2005 | 2716 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 1999 | 1711 | 0.030 |
Why?
|
| Receptors, Purinergic | 1 | 2014 | 70 | 0.030 |
Why?
|
| Metabolome | 1 | 2021 | 871 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 764 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2019 | 1623 | 0.030 |
Why?
|
| gamma-Synuclein | 1 | 2013 | 9 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2022 | 1391 | 0.030 |
Why?
|
| Survival Rate | 2 | 2013 | 13261 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1590 | 0.030 |
Why?
|
| Receptor, erbB-2 | 2 | 2000 | 2333 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 11276 | 0.030 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 58528 | 0.030 |
Why?
|
| Urinary Calculi | 1 | 2013 | 81 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2013 | 3830 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 1990 | 4750 | 0.030 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 1024 | 0.030 |
Why?
|
| Lymphatic Vessels | 1 | 2016 | 325 | 0.030 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 960 | 0.030 | |